AB BioTechnologies, Inc. (AB) is a contract development and manufacturing organization (CDMO) located in Bloomington, Indiana, USA. Founded in 2008 by formulation and lyophilization expert Dr. Jeff Schwegman, AB is an internationally renowned leader in lyophilization and formulation development for small and large molecules, suspensions, emulsions, tissues, and diagnostic products. Since starting out as a teaching and consulting firm in 2008, AB has grown exponentially to provide our clients more services, capabilities, instrumentation and laboratory space all housed inside our brand new state of the art GMP manufacturing facility. AB’s clients receive the dedicated attention of scientists who understand the science behind their projects, enabling them to clear the hurdles of manufacturing with ease. From early-stage development work to GMP manufacturing, AB BioTechnologies’ experienced team bring client projects from concept to clinic, and beyond.